OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation
Tauangtham Anekpuritanang, Maythad Uataya, Apichaya Claimon, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 3959-3969
Open Access | Times Cited: 9

Showing 9 citing articles:

Strategies for Radioiodine Treatment: What’s New
Clotilde Sparano, Sophie Moog, Julien Hadoux, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3800-3800
Open Access | Times Cited: 20

Blood Profiles in the Prediction of Radioiodine Refractory Papillary Thyroid Cancer: A Case–Control Study
Hanqing Liu, Qian Chen, Bohao Liu, et al.
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 535-546
Open Access | Times Cited: 5

ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer
Yuchen Jin, Xian Qiu, Ziyan He, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7

The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors
Άννα Πασπάλα, Georgia Bompetsi, Stavroula Α. Paschou, et al.
HORMONES (2024)
Closed Access | Times Cited: 1

APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
Sarah Siraj, Tariq Masoodi, Abdul K. Siraj, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1584-1584
Open Access | Times Cited: 6

Add-on radioiodine during long-term BRAF/MEK inhibition in patients with RAI-refractory thyroid cancers: a reasonable option?
Filipe Miguel Montes de Jesus, Vittoria Espeli, Gaetano Paone, et al.
Endocrine (2023) Vol. 81, Iss. 3, pp. 450-454
Open Access | Times Cited: 3

Nuclear Medicine in the Diagnosis and Management of Thyroid Nodules and Cancer
Nghi Nguyen, Satyanarayana Chekuri, Orhan K. Öz
(2024), pp. 81-128
Closed Access

The effect of sodium iodide symporter protein on ablation success in patients with differentiated thyroid cancer
Gözde Mütevelizade, Nazım Emrah Koçer, Mehmet Reyhan
Annals of Nuclear Medicine (2022) Vol. 36, Iss. 12, pp. 1050-1058
Closed Access

Mutação no gene BRAF em carcinoma diferenciado de tireoide avançado: um relato de caso
Juliana Lima von Ammon, Helton Estrela Ramos
Revista de Ciências Médicas e Biológicas (2021) Vol. 20, Iss. 3, pp. 476-479
Open Access

Page 1

Scroll to top